Sofosbuvir
Products in Health Canada’s databases that list Sofosbuvir as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 4
- 4 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 32
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| EPCLUSA (400 MG) | 02456370 | Marketed | Gilead Sciences Canada Inc | |
| HARVONI (400 MG) | 02432226 | Marketed | Gilead Sciences Canada Inc | |
| SOVALDI (400 MG) | 02418355 | Marketed | Gilead Sciences Canada Inc | |
| VOSEVI (400 MG) | 02467542 | Marketed | Gilead Sciences Canada Inc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- SOVALDIMay 8, 2025 · NOC 35322
- HARVONIMay 8, 2025 · NOC 35323
- EPCLUSAApril 10, 2025 · NOC 35164
- VOSEVIMarch 7, 2025 · NOC 34978
- EPCLUSAAugust 11, 2022 · NOC 28748
- VOSEVIOctober 8, 2021 · NOC 26808
- EPCLUSAOctober 6, 2021 · NOC 26790
- HARVONIJune 25, 2021 · NOC 26148
- SOVALDIJune 25, 2021 · NOC 26149
- EPCLUSAJune 25, 2021 · NOC 26150
- VOSEVIMay 21, 2021 · NOC 25927
- VOSEVIApril 16, 2021 · NOC 25693
- EPCLUSANovember 6, 2020 · NOC 24569
- HARVONIFebruary 4, 2020 · NOC 23170
- VOSEVIJanuary 28, 2020 · NOC 23158
- EPCLUSAJanuary 16, 2020 · NOC 23108
- EPCLUSASeptember 14, 2017 · NOC 19796
- VOSEVIAugust 16, 2017 · NOC 19660
- EPCLUSAAugust 1, 2017 · NOC 19624
- SOVALDIJuly 28, 2017 · NOC 19596
- HARVONIJuly 28, 2017 · NOC 19598
- HARVONIJune 15, 2017 · NOC 19417
- HARVONIMay 24, 2017 · NOC 19343
- HARVONIFebruary 13, 2017 · NOC 19078
- EPCLUSAJuly 11, 2016 · NOC 18265
- HARVONIJune 14, 2016 · NOC 18182
- SOVALDIMay 12, 2016 · NOC 18091
- HARVONIMay 12, 2016 · NOC 18092
- SOVALDIDecember 5, 2014 · NOC 16410
- HARVONIOctober 15, 2014 · NOC 16181
- SOVALDISeptember 30, 2014 · NOC 16200
- SOVALDIDecember 13, 2013 · NOC 15028